Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors. - Test2 - elhamkhani - TriplyDB

Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors.

Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors.

http://www.wikidata.org/entity/Q35588532

about

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer Small RNA Detection by in Situ Hybridization Methods MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2 Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells.HistoFlex--a microfluidic device providing uniform flow conditions enabling highly sensitive, reproducible and quantitative in situ hybridizations.Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer.VISTA is an immune checkpoint molecule for human T cells.Stromal expression of miR-21 identifies high-risk group in triple-negative breast cancer.A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.Highly specific plasmonic biosensors for ultrasensitive microRNA detection in plasma from pancreatic cancer patients.Involvement of microRNAs in lung cancer biology and therapy.Critical analysis of the potential for microRNA biomarkers in breast cancer management.MiR-21 expression in the tumor stroma of oral squamous cell carcinoma: an independent biomarker of disease free survival Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells.MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma A sensitive alternative for microRNA in situ hybridizations using probes of 2'-O-methyl RNA + LNA.Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.MicroRNAome genome: a treasure for cancer diagnosis and therapy.Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer.In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA.Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes.MicroRNA MIR21 and T Cells in Colorectal Cancer.Role of microRNAs in breast cancer.Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer Combined fluorescent in situ hybridization for detection of microRNAs and immunofluorescent labeling for cell-type markers.A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.MicroRNAs in colorectal cancer metastasis.MicroRNA-mediated breast cancer metastasis: from primary site to distant organs.miRNAs in breast cancer: ready for real time?MicroRNAs: relevant tools for a colorectal surgeon?MicroRNA biomarkers in glioblastoma.MicroRNA regulons in tumor microenvironment.Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization.Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study.Metastatic Pancreatic Adenocarcinoma After Total Pancreatectomy Islet Autotransplantation for Chronic Pancreatitis.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.

P2860

Q24569637-F1987DA3-79B4-4900-AFEE-E4C6E2AD3BC4 Q26774690-3FBCC6C8-25A7-4C16-AB61-680D83119659 Q27011992-3F232640-48F7-4C2D-BF3F-130A1ECB83C8 Q27311645-5D5A0A03-1E4E-4902-896D-AC0F03E77A9C Q33971452-AD846CF5-D03A-4BBA-B18F-0AA16A3CFE52 Q34037296-9A97510D-7523-48E2-AF21-5C65EDAB220D Q34241079-B5D7948C-B0BB-4B2C-AABD-D631DF7943E8 Q34413221-442E8BF4-A0B0-464E-BCC8-DD36BA7902E4 Q34647811-B3B29CCE-B06B-4310-9F74-1E28C4D6CB2C Q34664680-1D667B77-F42A-4940-9616-98C09943B9D7 Q34690617-734CF975-BC82-41B5-9A19-4A9F38C9A503 Q34771731-F6566522-DB81-4A29-ACC4-5FF9F6610BB3 Q35137273-BC218680-86AC-495A-B6D8-9DC5F9BA1907 Q35155103-B5A8B934-0BA5-4967-BAC2-10F22972E026 Q35190111-931279F0-DF43-4FA3-ACA6-50BBAFEF330D Q35194888-DCE2F643-96D0-41EF-A36A-A78B7F89DFE5 Q35196518-D49D6532-B9D7-40B2-8FFF-483CB2F0D779 Q35440962-82B58595-1F66-49BD-A6B8-2C7170FADB72 Q35561695-2137F9FD-AADE-4489-B751-9F951C6A179E Q35704188-7DB16C24-EF09-4A09-AFA8-BEF3FE72DC00 Q35799910-EB8EB263-AEBE-4DB5-9987-1DEDCFDBF825 Q35871752-5B795870-452D-41A1-B06A-CFDA41B48ED1 Q36284875-809E8AE6-B750-4776-BC17-1FF1C950A7C2 Q36320797-38793010-3F14-462F-ADD7-DD18CD21C9A0 Q36436728-3DB4A436-B0AF-4F63-AFCD-2FC16B568294 Q36677690-4186E0FC-E4BB-4837-8291-73A023241E12 Q37046660-73C75315-3998-4E71-8CBC-41A8DDF5CCA4 Q37093273-D991AEB7-E0C5-42D2-8A54-29AAE1DE7000 Q37189876-E82F7DFF-57FF-4524-BA1C-1D98C770598A Q37744279-8EF507CF-248E-4CF0-B700-C8B34BE814DA Q37894616-9240EED7-2A4B-4E49-B271-12EAE01289BE Q37941371-7ED7172F-A014-4AF2-B9DD-2F5E03BFC422 Q38003705-AB58EA11-FC6D-4CEA-938C-0CA08A544632 Q38004774-D1B3099A-ECB8-400C-8B9E-6165C1EF6B4A Q38108768-50346EB6-A9FA-429B-8CAF-2FE351235FBE Q38240791-DA29B5A7-90B2-4799-BFD1-4AF0AA972FA7 Q39368513-5FBD8502-9549-4602-95C8-D986571AD954 Q40186128-66E58D83-18E4-4C7F-80EA-5C9145007659 Q40989217-6DF9F470-9937-4509-93CF-5C57210C9AAD Q42184292-4219E0CC-F7F3-4A6B-BD5B-F8E1F1313382

P2860

Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors.

http://www.wikidata.org/entity/Q35588532

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Fluorescence-based codetection ...... NA expression in solid tumors.

@ast

Fluorescence-based codetection ...... NA expression in solid tumors.

@en

type

label

Fluorescence-based codetection ...... NA expression in solid tumors.

@ast

Fluorescence-based codetection ...... NA expression in solid tumors.

@en

prefLabel

Fluorescence-based codetection ...... NA expression in solid tumors.

@ast

Fluorescence-based codetection ...... NA expression in solid tumors.

@en

P1433

Q35588532-CA5E2629-B001-41BC-909B-174F1A1E3D35

P1476

Q35588532-6322C719-A473-40BD-BB2E-C7E98F02F098

P2093

Q35588532-102EB569-C78F-4382-A090-6944E85BD16D

Q35588532-1D5B0DB7-CF6D-4B23-885D-50F3EF44ECE7

Q35588532-27015645-272A-404C-ADC3-3B7E4D41D631

Q35588532-2EE2A87B-322A-4832-98A6-56B3D6F7209B

Q35588532-45BCB544-0A0C-4A01-B4FE-2D133EE0B7BB

Q35588532-48C1B5E6-DA35-4693-BE68-8F5DF3995A90

Q35588532-755222E6-9DD0-4EBB-914C-2CAA3C7B55B5

Q35588532-C040C617-6398-4EDE-AFA8-8953EA5F89E7

Q35588532-FD7BF4CA-C908-42D4-99FF-B3AEB1F924F7

P2860

Q35588532-04B61366-406E-4294-98C9-AB93D18D1432

Q35588532-087F7F91-9990-4BEF-9E3C-25C4487C32D3

Q35588532-0FFAF8FB-A305-4116-805B-FE2D8413D8A5

Q35588532-145D0952-CBD4-4754-A729-592B35A9B2ED

Q35588532-1CF8132C-4612-41B1-8757-AED432FF5D3D

Q35588532-1D4247F5-AD94-4C06-8AB3-4AFD44C0836A

Q35588532-2054D72D-2A88-4317-B157-4586B7711B6A

Q35588532-219850A5-03DD-4268-842F-3D60F59F4485

Q35588532-223A4C36-5A17-4346-8872-5A44C75683F1

Q35588532-25AEDBD8-2CBA-4A77-8D1B-7310319A3E42

P304

Q35588532-84B07704-EDBB-4DB6-A1ED-8A8988F4EA42

P31

Q35588532-E1FB2564-4251-4AE5-BD62-AD3746FD51A7

P356

Q35588532-1334A7E8-622A-4103-AF6E-8F93DC18A3F1

P407

Q35588532-36FED722-5F39-43BE-8726-08AAB4FEAE14

P433

Q35588532-B8ABE298-1417-45F5-9F5C-DB9F981A84A0

P478

Q35588532-0454D08B-A376-42E0-A0D5-98056BDACB9C

P50

Q35588532-714506B4-BE52-429A-9A01-E0C114DD1DD8

P577

Q35588532-9E81C5E2-E443-492E-B0AE-A5694AF64747

P698

Q35588532-84D9E4C5-9EF5-477F-9FAD-9D4D860FFF00

P921

Q35588532-311BADBB-F19B-40C7-9F8D-C4C53412D087

P932

Q35588532-E1D4A7B9-91CA-4563-94B5-FC93F6119BAB

P356

1078-0432.CCR-10-1152

P1433

Clinical Cancer Research

P1476

Fluorescence-based codetection ...... NA expression in solid tumors.

@en

P2093

Arief A Suriawinata

http://www.w3.org/2001/XMLSchema#string

Haoxu Ouyang

http://www.w3.org/2001/XMLSchema#string

Jose R Conejo-Garcia

http://www.w3.org/2001/XMLSchema#string

Lorenzo F Sempere

http://www.w3.org/2001/XMLSchema#string

Meir Preis

http://www.w3.org/2001/XMLSchema#string

Murray Korc

http://www.w3.org/2001/XMLSchema#string

Sakari Kauppinen

http://www.w3.org/2001/XMLSchema#string

Todd Yezefski

http://www.w3.org/2001/XMLSchema#string

Wendy Wells

http://www.w3.org/2001/XMLSchema#string

P2860

A microRNA expression signature of human solid tumors defines cancer gene targets

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

MicroRNAs: target recognition and regulatory functions

Modulation of mismatch repair and genomic stability by miR-155

Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma

MicroRNAs in immune regulation--opportunities for cancer immunotherapy

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

Suppression of cell growth and invasion by miR-205 in breast cancer

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

P304

4246-4255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-1152

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Asli Silahtaroglu

P577

2010-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20682703

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression

P932

3229296

http://www.w3.org/2001/XMLSchema#string